New method enables storage and controlled release of pharmaceutical substances in the body
Thanks to an invention by Freiburg scientists, it is now possible to dispense precise dosages of drugs locally in the body. A junior research group from the University of Freiburg’s Cluster of Excellence BrainLinks–BrainTools led by Dr. Maria Asplund and her doctoral candidate Christian Böhler has provided the foundations for a new molecular storage method that could find its way into clinical practice in the foreseeable future. The microsystems engineers, electrical engineers, and materials scientists have succeeded in creating a compound of organic and inorganic materials that is particularly well suited for the compact storage of pharmacologically active substances. The study was conducted in cooperation with a team from the Laboratory for Nanotechnology under Prof. Dr. Margit Zacharias from the Department of Microsystems Engineering (IMTEK) of the University of Freiburg and was published in the journal Scientific Reports.
The starting point for producing the storage system was the conversion of a synthetic material from a liquid to a solid state. The researchers succeeded for the first time ever in using so-called atomic layer deposition for a process of this kind. This technique involves applying gases to a synthetic material. The gases penetrate into the molecular structure of the material and strengthen it from the inside.
The team used the polymer polyethylene glycol as the starting material. It reacts with zinc oxide in the deposition process to form an organic–inorganic hybrid compound whose molecular structure is suitable for storing drugs or other similar substances. An additional advantage of this material is the fact that it is water-soluble.
This makes it suitable for use as a drug carrier, since it is easy to release the substances stored in it again. For dispensing the doses precisely, for example for transport into the bloodstream, the polymer PEDOT is required.
This is one of the main emphases of Asplund’s group: “Stated in simplified terms, the polymer works like a net with holes that open when a negative charge is applied and close when a positive charge is applied. This allows the molecules to be released in controlled dosages,” explains Böhler. It is enough to apply two thin films of the polymer to the surface of the hybrid material to ensure that the storage system is sufficiently stable and can precisely control the release of the stored substances.
The team from IMTEK developed a novel technology to improve the storage system: Similar systems produced previously were comparatively less compact, had a smaller storage volume, could not store molecules with different charges, and sometimes caused unintended chemical reactions. The researchers at IMTEK demonstrated in experiments with the substance fluorescein that the multilayered system exhibits ideal properties for dispensing precise doses of a broad spectrum of related molecules at a particular point over a particular period of time. In future experiments, the group aims to determine whether several different molecules can be stored at the same time or in neighboring chambers.
The technology would be particularly useful for so-called lab-on-a-chip methods, which involve the exchange and analysis of substances in a very small space. It could also be used in cancer treatment, for instance to release drugs directly onto a tumor from a reservoir under the skin. Researchers at IMTEK have already conducted tests on cell cultures indicating that the human body would be capable of accommodating an implant of this kind without complications.
Learn more: Apothecary Cabinet under the Skin
The Latest on: Drug delivery implant
[google_news title=”” keyword=”Drug delivery implant” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Drug delivery implant
- Nanofibers Industry Poised for Exponential Growth: 26% CAGR Anticipated from 2023 to 2028on May 2, 2024 at 2:13 am
BOSTON, May 2, 2024 /PRNewswire/ -- According to the latest BCC Research study, the demand for Global Markets and Technologies for Nanofibers is growing from $2.9 billion in 2023 to $9.4 billion by ...
- Senseonics gets FDA clearance to pair CGM implant with insulin pumpson April 30, 2024 at 7:54 pm
Analysts said the designation and planned one-year sensor could help Senseonics’ device appeal to more patients.
- Boy had touching reaction to hearing his parents for 1st time with cochlear implantson April 30, 2024 at 6:24 am
South Australian toddler, Nate, lit up when he heard his parents' voices thanks to his new implants.
- Biocompatible Polymers Market Poised for Explosive Growth: Reaching US$ 1.8 Billion by 2033on April 30, 2024 at 1:27 am
In 2023, the biocompatible polymers market is expected to be worth US$ 957 million. The market is expected to reach US$ 1,847.7 million by 2033, expanding at a 6.8% CAGR throughout the forecast period ...
- FDA approves Abbott's dissolving stent for blocked arteries below the kneeon April 29, 2024 at 6:55 am
Abbott has returned to the field of bio-absorbable, dissolving stents, and in somewhat uncharted territory. | Abbott has returned to the field of bio-absorbable, dissolving stents, and in somewhat ...
- Inflammasome Therapeutics Announces First Patient Dosed in Geographic Atrophy (GA) Clinical Trialon April 29, 2024 at 6:17 am
Inflammasome Therapeutics ( a private company developing a new class of inflammasome inhibitor drugs, Kamuvudines, as therapies for prevalent, degenerative diseases, announced the first patient has ...
- CroíValve’s Duo takes a unique approach for treating tricuspid regurgitationon April 26, 2024 at 2:05 pm
CroíValve is making inroads in the tricuspid regurgitation (TR) treatment market currently occupied by Abbott and Edwards.
- BCI maker Science acquires retinal implant from Pixium Visionon April 25, 2024 at 12:54 pm
Brain-computer interface developer Science Corporation acquired the IP and related assets for the Pixium Vision Prima implant.
- Global Injectable Drug Delivery Market Set to Soar, Reaching US$ 113.87 Billion by 2034on April 24, 2024 at 9:57 pm
Injectable Drug Delivery Market is expected to reach an impressive US$ 113.87 billion by the end of 2034, at a CAGR of 8.70%.
- Restoring sight is possible now with optogeneticson April 23, 2024 at 3:30 am
Several companies are experimenting with optogenetics to create a “bionic eye” that can restore sight in visually impaired people.
via Bing News